GSA Capital Partners’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,060
| Closed | -$75K | – | 1513 |
|
|
2022
Q1 | $75K | Buy |
+2,060
| New | +$75K | 0.01% | 1321 |
|
|
2021
Q4 | – | Sell |
-2,051
| Closed | -$152K | – | 1517 |
|
|
2021
Q3 | $152K | Buy |
+2,051
| New | +$152K | 0.02% | 1281 |
|
|
2020
Q1 | – | Sell |
-729
| Closed | -$146K | – | 1208 |
|
|
2019
Q4 | $146K | Buy |
729
+662
| +988% | +$133K | 0.02% | 1305 |
|
|
2019
Q3 | $17K | Sell |
67
-153
| -70% | -$38.8K | ﹤0.01% | 1342 |
|
|
2019
Q2 | $551K | Buy |
+220
| New | +$551K | 0.06% | 607 |
|